> Cerebramha turns brain MRI scans into quantitative, clinician-ready reports, measuring structural change the human eye cannot see. # Precision neuroimaging, powered by AI. Cerebramha transforms brain MRI scans into quantitative, clinician-ready reports. Our AI platform measures what the human eye cannot, enabling earlier detection and better outcomes. [Explore the Platform](/products) [Our Story](/about) Clinical-grade AI · Brain MRI analysis · One platform live, one in development ## Neuroimaging is broken. Radiologists read brain MRIs visually. Subtle volume loss, early atrophy, and structural changes go unnoticed until symptoms are undeniable. By then, it is often too late. Up to 70% of Alzheimer's cases are diagnosed after significant neurodegeneration has already occurred. ~15 min average time a radiologist spends reading a brain MRI. Subtle changes are easily missed. 5 to 10 yrs of neurodegeneration can precede clinical symptoms, invisible to the naked eye. Cerebramha audits every medical brain scan with AI and clinical precision. We deploy advanced deep learning agents to recover nuanced signs of early neurodegeneration, volume loss, and structural anomalies. ## Standard scans, quantified. Our AI pipeline processes standard brain MRI scans and outputs quantitative volumetric reports. No special hardware. Just upload and receive. ### Upload Standard brain MRI scans from any clinical scanner. No special hardware required. ### Analyze AI-powered preprocessing, registration, and segmentation across key brain regions. ### Report Clinician-ready volumetric report with normative comparisons and atrophy staging. ## From scan to report. Three steps: upload, analyze, review. [Cedawn](https://cedawn.cerebramha.com), our Alzheimer's platform, turns a standard brain MRI into a quantitative, clinician-ready report. 01 ### Upload Scan Upload a standard brain MRI from any clinical scanner. Optional clinical markers can be attached alongside the study. - Standard clinical MRI - Common imaging formats - No special hardware 02 ### AI Analysis Preprocessing, registration and segmentation run across ten clinically relevant brain regions. - 10 brain regions - Normative comparison - Under 5 minutes 03 ### View Results A quantitative volumetric report, written for a clinician to read and to keep with the patient record. - Regional volumes - Longitudinal tracking - Exportable summary Illustrative brain MRI. Not a Cerebramha output. ### What the report contains - Regional volume measurements - Comparison against normative reference ranges - Longitudinal change when prior scans exist - An exportable summary for the patient record Cedawn is live. Brain Tumour Segmentation is in development. Neither is cleared for diagnostic use. Products ## Clinical-grade AI tools for brain health. Live ### Alzheimer's Early Detection [Cedawn](https://cedawn.cerebramha.com), our Alzheimer's platform, is live. Volumetric analysis across clinically relevant brain regions. Quantifies structural change patterns associated with Alzheimer's disease progression. From upload to report in under 5 minutes. Not cleared for diagnostic use. Clinically relevant regions Normative comparison Longitudinal tracking Standard formats [Learn more about our technology](/products) 10 Brain regions analyzed per scan < 5 min From upload to quantitative report 1 Platform live ## Build the future of clinical AI with Cerebramha. [Contact Us](/contact) --- Canonical HTML: https://cerebramha.com/ Other pages: [/products](/products) · [/about](/about) · [/contact](/contact) · [/privacy](/privacy) Machine-readable resources: [/llms.txt](/llms.txt) · [/sitemap.xml](/sitemap.xml) · [/robots.txt](/robots.txt) · [/.well-known/agent-instructions.md](/.well-known/agent-instructions.md) Every page here is also served as Markdown via `Accept: text/markdown`. Cedawn, the Alzheimer's platform, is live; Brain Tumour Segmentation is in development. Neither is cleared for diagnostic use.